SGLT2抑制剂在2型糖尿病人群中心血管获益证据及机制的最新研究进展

R587.1%R541.6+1; 心血管不良事件是2型糖尿病患者的主要并发症,也是其死亡的首要原因.钠葡萄糖协同转运蛋白2抑制剂作为一种新型降糖药物,在2型糖尿病患者中的心血管获益已被众多大型临床试验证实.该文回顾了近期相关文献,就钠葡萄糖协同转运蛋白2抑制剂的心血管获益临床证据及其机制进行了综述....

Full description

Saved in:
Bibliographic Details
Published in现代医药卫生 Vol. 37; no. 15; pp. 2599 - 2604
Main Author 谢畅
Format Journal Article
LanguageChinese
Published 重庆医科大学附属第一医院心血管内科,重庆400016 2021
Subjects
钠葡萄糖协同转运蛋白2抑制剂
心血管获益
心力衰竭
综述
2型糖尿病
Online AccessGet full text
ISSN1009-5519
DOI10.3969/j.issn.1009-5519.2021.15.019

Cover

Abstract R587.1%R541.6+1; 心血管不良事件是2型糖尿病患者的主要并发症,也是其死亡的首要原因.钠葡萄糖协同转运蛋白2抑制剂作为一种新型降糖药物,在2型糖尿病患者中的心血管获益已被众多大型临床试验证实.该文回顾了近期相关文献,就钠葡萄糖协同转运蛋白2抑制剂的心血管获益临床证据及其机制进行了综述.
AbstractList R587.1%R541.6+1; 心血管不良事件是2型糖尿病患者的主要并发症,也是其死亡的首要原因.钠葡萄糖协同转运蛋白2抑制剂作为一种新型降糖药物,在2型糖尿病患者中的心血管获益已被众多大型临床试验证实.该文回顾了近期相关文献,就钠葡萄糖协同转运蛋白2抑制剂的心血管获益临床证据及其机制进行了综述.
Author 谢畅
AuthorAffiliation 重庆医科大学附属第一医院心血管内科,重庆400016
AuthorAffiliation_xml – name: 重庆医科大学附属第一医院心血管内科,重庆400016
Author_xml – sequence: 1
  fullname: 谢畅
BookMark eNrjYmDJy89LZWBQMTTQM7Y0s9TP0sssLs7TMzQwsNQ1NTW01DMyMDLUMzTVMzC0ZGHghItzMPAWF2cmGZgaGpubGJkbcjJEBbv7hBg965r4tGPb086mp3NWGD2d1_1887SnG_Y_n976ZNeu5_uWPNmx9un-5hcLG56vW_iib_vz2V0v1jc-6133tL_r2ZxdQJ3PZ7U8m9PwbNqG5wumPF-57cX-2U83TuVhYE1LzClO5YXS3Azqbq4hzh665Yl5aYl56fFZ-aVFeUCZ-IqUysryYpCbDU2BLjYmXiUA3n5svw
ClassificationCodes R587.1%R541.6+1
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1009-5519.2021.15.019
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EndPage 2604
ExternalDocumentID xdyyws202115019
GroupedDBID -05
-0E
-SE
-S~
.5D
2B.
2RA
4A8
5SA
5VR
92F
92I
92L
92M
93N
9D9
9DE
AAITT
ABDBF
ABJNI
ACGFS
ACUHS
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CAJEE
CCEZO
CIEJG
CQIGP
CW7
CW9
EOJEC
ESX
FA0
J.9
JUIAU
M~T
OBODZ
PB1
PB7
PSX
Q--
Q-4
R-E
RT5
S..
T8U
TCJ
TGQ
U1F
U1G
U5E
U5O
W91
WFFXF
~WA
ID FETCH-wanfang_journals_xdyyws2021150193
ISSN 1009-5519
IngestDate Thu May 29 03:59:11 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 15
Keywords 钠葡萄糖协同转运蛋白2抑制剂
心血管获益
心力衰竭
综述
2型糖尿病
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-wanfang_journals_xdyyws2021150193
ParticipantIDs wanfang_journals_xdyyws202115019
PublicationCentury 2000
PublicationDate 2021
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – year: 2021
  text: 2021
PublicationDecade 2020
PublicationTitle 现代医药卫生
PublicationTitle_FL Journal of Modern Medicine & Health
PublicationYear 2021
Publisher 重庆医科大学附属第一医院心血管内科,重庆400016
Publisher_xml – name: 重庆医科大学附属第一医院心血管内科,重庆400016
SSID ssib051374271
ssj0002402475
Score 4.501671
Snippet R587.1%R541.6+1; 心血管不良事件是2型糖尿病患者的主要并发症,也是其死亡的首要原因.钠葡萄糖协同转运蛋白2抑制剂作为一种新型降糖药物,在2型糖尿病患者中的心血管获益已...
SourceID wanfang
SourceType Aggregation Database
StartPage 2599
Title SGLT2抑制剂在2型糖尿病人群中心血管获益证据及机制的最新研究进展
URI https://d.wanfangdata.com.cn/periodical/xdyyws202115019
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  issn: 1009-5519
  databaseCode: ABDBF
  dateStart: 20141215
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  omitProxy: true
  ssIdentifier: ssj0002402475
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxNBFB9qCuJFFBW_yaEPT4n7vTPHnWRjEfVihOKlZLupniLYFG1P9Qs0oiJoBRvFggc9WCtClRzMP9PN5s_wvdnNdqmlVWFZXmZ_895v5zF5b2ZnZxmbCB1KbO3ZUtOd0UoYr8OSwEhS4oErcEwUao56XHD5ijN5zbo4ZU-N7XuXW7U03w7KM4s7vlfyP17FMvQrvSX7D57NlGIByuhfPKOH8fxXPr564VLdAN8B7oHQwbeBc5COEgRwgwRRAS-VfOASfBekCUKBpAayRiXCBW6Db4H06CCMD56lSjh4VQWuATfBx586LY9AjOeTjCXcB-kqPZKoEAbBumJWJRgRqqlLDhEiExlXrOUBt9JLpNkhejIxoYGwlCAUmBMNtEJ8dEg-nDnKrQlGTDRFW4JnKisVkolklVhRCQqqHVCzyBY2K90aeIa6gig7PyFibE2FgI9N65IWIoHUnZwZJOqmrsDmQ5kEtOdQLSHUfSbUfQWu0JG0Mt15pkeBPWPXdrfJNLltZNSo_MnNUul2LvTQYyrMX0U-NiUb4oz6oJ2PNHbyYak0a8FhqbVTRDSFI1REJBvlzEaZGq6s05a1YisTyNZn3g0XFu7MEQbHC7Sp7rhB010FNu7JqqyN_rBt3XQtIx1PUOpDj-ostbl1Zmk_m0hpnN-NhHpnrjXbaN3IpXf1Q-xgOi4rekknO8zGFm8eYddVBxt0XkaPN6In96PuJyN6_zT-vhyt9-M3jzZ7vfjXx82fX6L-g-HqUry2Onz-I17pDL_eGzxbi150Bt0e1ozfPhx0lwbL6_GHV_HnjWF_Jfr2-ig7V_PrlclSymc67fBz09taxTzGCq1breZxVtQaoeFiZh3ggMYKA85FU9NDpzGjuY3Q4cEJVtxL28m9IafYAZKTCcDTrNC-Pd88gylxOzibOuY3aWiRdQ
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SGLT2%E6%8A%91%E5%88%B6%E5%89%82%E5%9C%A82%E5%9E%8B%E7%B3%96%E5%B0%BF%E7%97%85%E4%BA%BA%E7%BE%A4%E4%B8%AD%E5%BF%83%E8%A1%80%E7%AE%A1%E8%8E%B7%E7%9B%8A%E8%AF%81%E6%8D%AE%E5%8F%8A%E6%9C%BA%E5%88%B6%E7%9A%84%E6%9C%80%E6%96%B0%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95&rft.jtitle=%E7%8E%B0%E4%BB%A3%E5%8C%BB%E8%8D%AF%E5%8D%AB%E7%94%9F&rft.au=%E8%B0%A2%E7%95%85&rft.date=2021&rft.pub=%E9%87%8D%E5%BA%86%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91%2C%E9%87%8D%E5%BA%86400016&rft.issn=1009-5519&rft.volume=37&rft.issue=15&rft.spage=2599&rft.epage=2604&rft_id=info:doi/10.3969%2Fj.issn.1009-5519.2021.15.019&rft.externalDocID=xdyyws202115019
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fxdyyws%2Fxdyyws.jpg